http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2771159-C2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a057608770ee44280b4875b3ffbc3ab9 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2893 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-167 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-284 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2086 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2095 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0056 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61J3-10 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-167 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-28 |
| filingDate | 2017-11-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b49759bf99a0ebe3a85ff9b7ea9c9e7d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2d2ace805623a3f55f031a993d89d324 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dfe645f8d37962538202357880e05948 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2453fe46a2d3eb7e9aeb6a517116666a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e750f3abe6122b7bb8fc3c38cf4ae7a4 |
| publicationDate | 2022-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2771159-C2 |
| titleOfInvention | Method for obtaining dosed coated form |
| abstract | FIELD: pharmacy. n SUBSTANCE: group of inventions relates to the field of pharmacy, namely to a method for obtaining a dosed form containing at least one pharmaceutically active ingredient, wherein the method includes following stages: (i) addition, in order, the first powder layer, the second powder layer and the third powder layer to a press mold to provide a billet of the specified dosed form, wherein the first and the third powder layers contain a surface-stabilizing agent, and the second powder layer contains at least one activator and a pharmaceutically active ingredient, where the activator has Q value of less than 75; and the surface-stabilizing agent has water solubility from 19 to about 48 MPa 1/2 ; (ii) application of energy of radio-frequency radiation in the range from about 1 MHz to about 100 MHz during a sufficient time period to the billet of the stage (i) for preliminary binding of at least one activator in the dosed form; and (iii) application of heating to the billet of the stage (i) during a sufficient time period for stabilizing the dosed form (options) and to an oral dosed form. n EFFECT: solving problems of brittleness, fragility and chipping of the resulting dosed forms. n 19 cl, 8 tbl, 8 ex |
| priorityDate | 2016-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 500.